首页> 外文期刊>Canadian journal of surgery: Journal canadien de chirurgie >Incidental thyroid 'PETomas': clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.
【24h】

Incidental thyroid 'PETomas': clinical significance and novel description of the self-resolving variant of focal FDG-PET thyroid uptake.

机译:偶发性甲状腺“ PETomas”:局灶性FDG-PET甲状腺摄取的自分辨变异的临床意义和新颖描述。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Recent series of incidental thyroid activity on fluorodeoxyglucose positron emission tomography (FDG-PET) in patients evaluated for nonthyroidal malignancy, which we refer to as a "PEToma," have suggested that such lesions are associated with a significant incidence of primary thyroid cancer. METHODS: We retrospectively reviewed 6457 FDG-PET scans performed on 4726 patients from May 2004 to March 2007. We reviewed the cases of patients whose PET or computed tomography (CT) radiology reports described PET uptake within the thyroid to identify incidence and malignant potential of PETomas and evaluate their clinical and histopathologic features. RESULTS: We found that 160 patients (3.4%) had incidental, abnormal FDG uptake in the thyroid gland, 103 of whom had focal uptake (the PEToma group). Of these patients, 50 (48%) underwent further investigations, including ultrasonography in 48, fine-needle aspiration cytology in 38 and computed tomography in 3. Ten patients underwent surgery, and papillary thyroid cancer was identified in 9. The remaining 53 patients with PETomas underwent no further investigation. Interestingly, 5 patients who had focal uptake within the thyroid showed either spontaneous resolution on repeat FDG-PET (self-resolving) or no focal lesion on subsequent ultrasonography (false-positive). CONCLUSION: The incidence of papillary thyroid cancer in the present series is similar to that in the literature. Although some patients will show self-resolving or false-positive focal thyroid uptake on FDG-PET, we believe that, if the patient's clinical status permits, the evaluation of patients with incidental thyroid PEToma should include ultrasonographic confirmation and fine-needle aspiration cytology.
机译:背景:最近对一系列评估了非甲状腺恶性肿瘤的患者进行的一系列氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)甲状腺活动研究,我们将其称为“ PEToma”,这表明这些病变与原发性甲状腺癌的高发病率相关。方法:我们回顾性分析了2004年5月至2007年3月对4726例患者进行的6457例FDG-PET扫描。我们回顾了PET或计算机断层扫描(CT)放射学报告描述了甲状腺内PET摄取的患者病例,以鉴定其发生率和恶性潜能。 PEToma并评估其临床和组织病理学特征。结果:我们发现160例患者(3.4%)在甲状腺中偶然摄取了异常的FDG,其中103例是局灶性摄取(PEToma组)。在这些患者中,有50名(48%)接受了进一步的检查,包括超声检查48例,细针穿刺细胞学检查38例和计算机断层扫描3例。十例接受了手术,甲状腺乳头状癌的诊断为9例。 PETomas无需进一步调查。有趣的是,在甲状腺内有局灶性摄取的5例患者在重复FDG-PET(自解决)后自发消退或在随后的超声检查中无局灶性病变(假阳性)。结论:本系列中甲状腺乳头状癌的发病率与文献报道相似。尽管有些患者会通过FDG-PET表现出自我解决的或假阳性的局灶性甲状腺摄取,但我们认为,如果患者的临床状况允许,对偶发性甲状腺PEToma患者的评估应包括超声检查和细针穿刺细胞学检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号